Changes in nitric oxide metabolite levels in stimulated substantia nigra neurons

NeuroReport

Volumn 8, Issue 9-10, 1997, Pages 2121-2125

  Zecca, L ^a   Fariello, R G ^b   Galimberti, M ^c   Racagni, G ^a,d   Ambrosini, A ^d  

^a INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c Gruppo Lepetit SpA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Depolarization; Glutamate receptors; Mesencephalic neurons; Metabolism; Nitrate; Nitric oxide; Nitrite

Indexed keywords

GLUTAMATE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID; NITRATE; NITRIC OXIDE; NITRITE; POTASSIUM; QUISQUALIC ACID;

ANIMAL CELL; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; DEPOLARIZATION; EMBRYO; MESENCEPHALON; METABOLITE; MOUSE; NERVE CELL CULTURE; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

EID: 0030742928     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199707070-00007     Document Type: Article

References (21)

1. Dawson TM and Snyder SH. J Neurosci 14, 5147-5159 (1994).
2. Schmidt HHHW and Walter U. Cell 78, 919-925 (1994).
3. Garthwaite J and Boulton CL. Annu Rev Physiol 57, 683-706 (1995).
4. Manzoni O, Prezeau L, Marin P et al. Neuron 8, 653-662 (1992).
5. Montague PR, Gancayco CD, Winn MJ et al. Science 263, 973-977 (1994).
6. Ohkuma S, Katsura M, Guo J-L et al. Mol Brain Res 31, 185-193 (1995).
7. Moncada S, Palmer RMJ and Higgs EA. Pharmacol Rev 43, 109-142 (1991).
8. Butler AR, Flitney FW and Williams DLH. Trends Pharmacol Sci 16, 18-22 (1995).
9. Gross SS and Wolin MS. Annu Rev Physiol 57, 737-769 (1995).
10. Wennmalm A, Lanne B and Petersson AS. Anal Biochem 187, 359-369 (1990).
11. Dawson TM. Cerebrovasc Brain Metab Rev 6, 299-324 (1994).
12. Chao CC, Shuxian H, Molitor TW et al. J Immunol 149, 2736-2741 (1992).
13. Dawson VL, Brahmbhatt HP, Mong JA and Dawson TM. Neuropharmacology 33, 1425-1430 (1994).
14. Hewett SJ, Csernansky CA and Choi DW. Neuron 13, 487-494 (1994).
15. Garthwaite G and Garthwaite J. Neuropharmacology 33, 1431-1438 (1994).
16. Lafon-Cazal M, Culcasi M, Gaven F et al. Neuropharmacology 32, 1259-1266 (1993).
17. Collingridge GL and Lester RAJ. Pharmacol Rev 41, 143-210 (1989).
18. Ambrosini A, Bresciani L, Fracchia S et al. Mol Pharmacol 47, 1057-1064 (1995).
19. Luo D, Knezevich S and Vincent SR. Neuroscience 57, 897-900 (1993).
20. Luo D and Vincent SR. Neuropharmacology 33, 1345-1350 (1994).
21. Gorbunov N and Esposito E. J Neurochem 62, 2205-2211 (1994).